Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 86-5300 (Yaz) for Dysmenorrhea
NCT02617537Phase 3Withdrawn
- Sponsor
- Bayer
- Start
- Jan 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in dysmenorrhea, sponsored by Bayer. Planned start Jan 2016; status: withdrawn.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT02617537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02617537.